Delivery Order SPE2DB20D2014-SPE2DB24FA26F
Award Date 11/3/23
Potential Completion Date 11/6/23
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM42E, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,485.50 delivery order contract is for the supply of 4,563,458,779 units of Rosuvastatin Calcium 40 mg tablets, with a completion date of January 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 500 units of Rosuvastatin Calcium 40 mg tablets. The $15,497.62 firm fixed-price delivery order contract has a completion date of May 22, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $59,871.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,618,267 units of rosuvastatin calcium 40 mg tablets over a period ending on August 29, 2024. This is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $19,773.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of 4,562,237,166 units of Rosuvastatin Calcium 40 mg tablets. The contract is a Firm Fixed Price Delivery Order that runs through September 20, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,993.20 firm fixed-price delivery order is for the supply of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, with a performance period through March 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $157,458.83 firm fixed-price delivery order is for the supply of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, to support military healthcare programs. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with...
- The federal contract award SPE2DB22D2206|SPE2DB23FHJ61 was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4,561,055,395 units of Rosuvastatin Calcium 40 mg tablets. The $86,664.85 firm fixed-price delivery order contract has a completion date of May 26, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,164.29, is for the delivery of Rosuvastatin Calcium 40 mg tablets. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award, with ID SPE2DX15D6044|SPE2DX24FCQUR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The $1,807.20 firm fixed price delivery order is for the provision of 4,564,288,624 units of Rosuvastatin Calcium 40 mg tablets. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,668.55 firm fixed-price delivery order contract covers the supply of 500 count bottles of 5 mg Rosuvastatin Calcium tablets. The contract has an ultimate completion date of July 30, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...